LIST OF TABLES
UU
TABLE 1 EXOSOMES USED AS DRUG/GENE DELIVERY CARRIERS.
TABLE 2 COMPARISON OF CONVENTIONAL AND MICROFLUIDICS-BASEDEXOSOME ISOLATION TECHNIQUES
TABLE 3 STRATEGIC RESEARCH INITIATIVES BY MARKET PLAYERS
TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 5 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 6 NORTH AMERICA HYBRID EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 NORTH AMERICA NATURAL EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 NORTH AMERICA NATURAL EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 9 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 10 NORTH AMERICA MESENCHYMAL STEM CELLS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 NORTH AMERICA DENDRITIC CELLS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 NORTH AMERICA BLOOD IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 NORTH AMERICA BLOOD IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 14 NORTH AMERICA BODY FLUIDS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 NORTH AMERICA BODY FLUIDS IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 16 NORTH AMERICA MILK IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 NORTH AMERICA SALIVA IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 NORTH AMERICA URINE IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY, 2017-2026 (USD MILLION)
TABLE 21 NORTH AMERICA CHEMOTHERAPY IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 NORTH AMERICA IMMUNOTHERAPY IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA GENE THERAPY IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA BIO MACROMOLECULES IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA BIO MACROMOLECULES IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA SMALL MOLECULES IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA ONCOLOGY IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA ONCOLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 31 NORTH AMERICA CARDIAC DISORDERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 NORTH AMERICA METABOLIC DISORDERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 NORTH AMERICA NEUROLOGY IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 NORTH AMERICA NEUROLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 35 NORTH AMERICA BLOOD DISORDERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 NORTH AMERICA GYNECOLOGY DISORDERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 37 NORTH AMERICA INFLAMMATORY DISORDERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 NORTH AMERICA ORGAN TRANSPLANTATION IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 NORTH AMERICA OTHERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 40 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 41 NORTH AMERICA PARENTERAL IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 42 NORTH AMERICA ORAL IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 43 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 44 NORTH AMERICA HOSPITALS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 45 NORTH AMERICA RESEARCH & ACADEMIC INSTITUTES IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 46 NORTH AMERICA DIAGNOSTIC CENTERS IN EXOSOME THERAPEUTIC MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 47 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY COUNTRY 2017-2026 (USD MILLION)
TABLE 48 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 49 NORTH AMERICA NATURAL EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 50 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 51 NORTH AMERICA BLOOD IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 52 NORTH AMERICA BODY FLUIDS IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 53 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY, 2017-2026 (USD MILLION)
TABLE 54 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 55 NORTH AMERICA BIO MACROMOLECULES IN EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 56 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 57 NORTH AMERICA ONCOLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 58 NORTH AMERICA NEUROLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 59 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 60 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 61 U.S. EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 62 U.S. NATURAL EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 63 U.S. EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 64 U.S. BLOOD IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 65 U.S. BODY FLUIDS IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 66 U.S. EXOSOME THERAPEUTIC MARKET, BY THERAPY, 2017-2026 (USD MILLION)
TABLE 67 U.S. EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 68 U.S. BIO MACROMOLECULES IN EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 69 U.S. EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 70 U.S. ONCOLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 71 U.S. NEUROLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 72 U.S. EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 73 U.S. EXOSOME THERAPEUTIC MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 74 MEXICO EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 75 MEXICO NATURAL EXOSOMES IN EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 76 MEXICO EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 77 MEXICO BLOOD IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 78 MEXICO BODY FLUIDS IN EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
TABLE 79 MEXICO EXOSOME THERAPEUTIC MARKET, BY THERAPY, 2017-2026 (USD MILLION)
TABLE 80 MEXICO EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 81 MEXICO BIO MACROMOLECULES IN EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
TABLE 82 MEXICO EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 83 MEXICO ONCOLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 84 MEXICO NEUROLOGY IN EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 85 MEXICO EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 86 MEXICO EXOSOME THERAPEUTIC MARKET, BY END USER, 2017-2026 (USD MILLION)
LIST OF FIGURE
LIST OF FIGURES
FIGURE 1 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA EXOSOME THERAPEUTIC MARKET
FIGURE 8 LYME DISEASE-REPORTED CONFIRMED AND PROBABLE CASES BY SEX OF PATIENT, UNITED STATES, 2017
FIGURE 9 COLORECTAL CANCER RATES PER 100,000 IN 2018: BOTH SEXES
FIGURE 10 COLORECTAL CANCER RATES IN 2018 PER 100,000 FOR MEN AND WOMEN
FIGURE 11 COLON & RECTUM CANCER SURVIVORS FROM 2016 TO 2026
FIGURE 12 AGEING WORLD POPULATION (NUMBER OF PERSONS AGED 60 YEARS OR OLDER IN MILLIONS)
FIGURE 13 AGEING NORTH AMERICA POPULATION (IN MILLION)
FIGURE 14 AGEING EUROPE POPULATION (IN MILLION)
FIGURE 15 AGEING ASIA-PACIFIC POPULATION (IN MILLION)
FIGURE 16 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA EXOSOME THERAPEUTIC MARKET AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 18 INCREASING PREVALENCE OF LYME DISEASE, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE AND OTHER CHRONIC DEGENERATIVE DISEASES IS DRIVING THE NORTH AMERICA EXOSOME THERAPEUTIC MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 19 HYBRID EXOSOMES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXOSOME THERAPEUTIC MARKET IN 2019 & 2026
FIGURE 20 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE (2018)
FIGURE 21 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE, 2017-2026 (USD MILLION)
FIGURE 22 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE, CAGR (2019-2026)
FIGURE 23 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE (2018)
FIGURE 25 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE, 2017-2026 (USD MILLION)
FIGURE 26 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE, CAGR (2019-2026)
FIGURE 27 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY SOURCE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY (2018)
FIGURE 29 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY, 2017-2026 (USD MILLION)
FIGURE 30 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY, CAGR (2019-2026)
FIGURE 31 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY THERAPY, LIFELINE CURVE
FIGURE 32 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY (2018)
FIGURE 33 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, 2017-2026 (USD MILLION)
FIGURE 34 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, CAGR (2019-2026)
FIGURE 35 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY TRANSPORTING CAPACITY, LIFELINE CURVE
FIGURE 36 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION (2018)
FIGURE 37 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
FIGURE 38 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION, CAGR (2019-2026)
FIGURE 39 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 40 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION (2018)
FIGURE 41 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
FIGURE 42 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, CAGR (2019-2026)
FIGURE 43 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 44 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER (2018)
FIGURE 45 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER, 2017-2026 (USD MILLION)
FIGURE 46 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER, CAGR (2019-2026)
FIGURE 47 NORTH AMERICA EXOSOME THERAPEUTIC MARKET, BY END USER, LIFELINE CURVE
FIGURE 48 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: SNAPSHOT (2018)
FIGURE 49 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: BY COUNTRY (2018)
FIGURE 50 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: BY COUNTRY (2019 & 2026)
FIGURE 51 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: BY COUNTRY (2018 & 2026)
FIGURE 52 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: BY TYPE (2019-2026)
FIGURE 53 NORTH AMERICA EXOSOME THERAPEUTIC MARKET: COMPANY SHARE 2018 (%)
